Clinical Profile and Management of Neovascular Glaucoma in North India

Purpose: To report the etiology, clinical features, treatment and outcomes of neovascular glaucoma (NVG) in a tertiary care ophthalmic center. Background: NVG is a devastating ocular disease often leading to loss of vision. The current standard of care includes retinal phtocoagulation and control of...

Full description

Saved in:
Bibliographic Details
Main Authors: Ketaki Rajurkar, Suneeta Dubey, Monica Gandhi, Prachi Gurav, Julie Pegu
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2022-10-01
Series:Delhi Journal of Ophthalmology
Subjects:
Online Access:https://journals.lww.com/10.4103/dljo.dljo_56_23
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849314439710375936
author Ketaki Rajurkar
Suneeta Dubey
Monica Gandhi
Prachi Gurav
Julie Pegu
author_facet Ketaki Rajurkar
Suneeta Dubey
Monica Gandhi
Prachi Gurav
Julie Pegu
author_sort Ketaki Rajurkar
collection DOAJ
description Purpose: To report the etiology, clinical features, treatment and outcomes of neovascular glaucoma (NVG) in a tertiary care ophthalmic center. Background: NVG is a devastating ocular disease often leading to loss of vision. The current standard of care includes retinal phtocoagulation and control of increased intraocular pressure with medical and surgical therapy like trabeculectomy, Ahmed Glaucoma Valve (AGV) and Trans scleral cyclophotocoagulation (TSCPC) with studies comparing them showing varied results. We compared these treatment modalities to find out which is better for IOP control. Methods: Retrospective file review. Results: 230 eyes of 217 patients with NVG were studied. Mean age of the population was 56.99 ± 13.8 years. Venous occlusion (37.4%) was the commonest cause of NVG followed by diabetic retinopathy (35.2%). All the patients were managed medically to begin with. Ninety one patients underwent surgical management. Pan retinal photocoagulation was done for 68.75% patients. Anti- vascular endothelial growth factor (VEGF) was given intravitreally for 56.25% patients prior to surgery. Thirty six patients underwent trabeculectomy with Mitomycin C (MMC), eleven patients underwent AGV implantation and thirty three underwent TSCPC. Best corrected visual acuity at baseline was 2.24 ± 0.99. Final visual acuity was 2.67 ± 1.1. Best corrected visual acuity (BCVA) was either stable or improved from baseline in 46.25% patients and deteriorated in 53.5%. All three modalities were equally effective in reducing IOP from baseline (p = 0.00) and there was no statistically significant difference between them taking IOP into consideration as success criteria (p = 0.60). Hyphaema was the commonest complication (22.5%). Conclusion: Venous occlusion was the commonest cause of NVG in our setup. All three modalities of treatment, AGV, trabeculectomy with MMC and TSCPC are effective in controlling the disease process. The visual prognosis however remains poor despite surgical treatment due to late presentation and fast progression.
format Article
id doaj-art-99938d7fbf5e4ca88c92d3e98e1567e6
institution Kabale University
issn 0972-0200
2454-2784
language English
publishDate 2022-10-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Delhi Journal of Ophthalmology
spelling doaj-art-99938d7fbf5e4ca88c92d3e98e1567e62025-08-20T03:52:28ZengWolters Kluwer Medknow PublicationsDelhi Journal of Ophthalmology0972-02002454-27842022-10-01326192310.4103/dljo.dljo_56_23Clinical Profile and Management of Neovascular Glaucoma in North IndiaKetaki RajurkarSuneeta DubeyMonica GandhiPrachi GuravJulie PeguPurpose: To report the etiology, clinical features, treatment and outcomes of neovascular glaucoma (NVG) in a tertiary care ophthalmic center. Background: NVG is a devastating ocular disease often leading to loss of vision. The current standard of care includes retinal phtocoagulation and control of increased intraocular pressure with medical and surgical therapy like trabeculectomy, Ahmed Glaucoma Valve (AGV) and Trans scleral cyclophotocoagulation (TSCPC) with studies comparing them showing varied results. We compared these treatment modalities to find out which is better for IOP control. Methods: Retrospective file review. Results: 230 eyes of 217 patients with NVG were studied. Mean age of the population was 56.99 ± 13.8 years. Venous occlusion (37.4%) was the commonest cause of NVG followed by diabetic retinopathy (35.2%). All the patients were managed medically to begin with. Ninety one patients underwent surgical management. Pan retinal photocoagulation was done for 68.75% patients. Anti- vascular endothelial growth factor (VEGF) was given intravitreally for 56.25% patients prior to surgery. Thirty six patients underwent trabeculectomy with Mitomycin C (MMC), eleven patients underwent AGV implantation and thirty three underwent TSCPC. Best corrected visual acuity at baseline was 2.24 ± 0.99. Final visual acuity was 2.67 ± 1.1. Best corrected visual acuity (BCVA) was either stable or improved from baseline in 46.25% patients and deteriorated in 53.5%. All three modalities were equally effective in reducing IOP from baseline (p = 0.00) and there was no statistically significant difference between them taking IOP into consideration as success criteria (p = 0.60). Hyphaema was the commonest complication (22.5%). Conclusion: Venous occlusion was the commonest cause of NVG in our setup. All three modalities of treatment, AGV, trabeculectomy with MMC and TSCPC are effective in controlling the disease process. The visual prognosis however remains poor despite surgical treatment due to late presentation and fast progression.https://journals.lww.com/10.4103/dljo.dljo_56_23neovascular glaucomaetiologytreatment
spellingShingle Ketaki Rajurkar
Suneeta Dubey
Monica Gandhi
Prachi Gurav
Julie Pegu
Clinical Profile and Management of Neovascular Glaucoma in North India
Delhi Journal of Ophthalmology
neovascular glaucoma
etiology
treatment
title Clinical Profile and Management of Neovascular Glaucoma in North India
title_full Clinical Profile and Management of Neovascular Glaucoma in North India
title_fullStr Clinical Profile and Management of Neovascular Glaucoma in North India
title_full_unstemmed Clinical Profile and Management of Neovascular Glaucoma in North India
title_short Clinical Profile and Management of Neovascular Glaucoma in North India
title_sort clinical profile and management of neovascular glaucoma in north india
topic neovascular glaucoma
etiology
treatment
url https://journals.lww.com/10.4103/dljo.dljo_56_23
work_keys_str_mv AT ketakirajurkar clinicalprofileandmanagementofneovascularglaucomainnorthindia
AT suneetadubey clinicalprofileandmanagementofneovascularglaucomainnorthindia
AT monicagandhi clinicalprofileandmanagementofneovascularglaucomainnorthindia
AT prachigurav clinicalprofileandmanagementofneovascularglaucomainnorthindia
AT juliepegu clinicalprofileandmanagementofneovascularglaucomainnorthindia